BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 19940136)

  • 1. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
    Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
    J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
    Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
    DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
    Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
    J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.
    Fadda E
    Biophys J; 2013 Jun; 104(11):2503-11. PubMed ID: 23746523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
    Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
    PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA repair gets physical: mapping an XPA-binding site on ERCC1.
    Croteau DL; Peng Y; Van Houten B
    DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.
    Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T
    EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
    Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
    Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2.
    Sabatella M; Pines A; Slyskova J; Vermeulen W; Lans H
    Cell Mol Life Sci; 2020 May; 77(10):2005-2016. PubMed ID: 31392348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair.
    Li L; Peterson CA; Lu X; Legerski RJ
    Mol Cell Biol; 1995 Apr; 15(4):1993-8. PubMed ID: 7891694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formation of UV-induced chromosome aberrations involves ERCC1 and XPF but not other nucleotide excision repair genes.
    Chipchase MD; Melton DW
    DNA Repair (Amst); 2002 Apr; 1(4):335-40. PubMed ID: 12509251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function and Interactions of ERCC1-XPF in DNA Damage Response.
    Faridounnia M; Folkers GE; Boelens R
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
    Gentile F; Tuszynski JA; Barakat KH
    J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
    Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
    Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.
    Obermann R; Yemane B; Jarvis C; Franco FM; Kyriukha Y; Nolan W; Gohara B; Krezel AM; Wildman SA; Janetka JW
    ChemMedChem; 2024 Apr; 19(8):e202300648. PubMed ID: 38300970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domains in the XPA protein important in its role as a processivity factor.
    Bartels CL; Lambert MW
    Biochem Biophys Res Commun; 2007 Apr; 356(1):219-25. PubMed ID: 17349973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the XPA and ssDNA-binding surfaces on the central domain of human ERCC1 reveals evidence for subfunctionalization.
    Tripsianes K; Folkers GE; Zheng C; Das D; Grinstead JS; Kaptein R; Boelens R
    Nucleic Acids Res; 2007; 35(17):5789-98. PubMed ID: 17720715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles of XPF-ERCC1 and Rad1-Rad10-Saw1 in replication-coupled and uncoupled inter-strand crosslink repair.
    Seol JH; Holland C; Li X; Kim C; Li F; Medina-Rivera M; Eichmiller R; Gallardo IF; Finkelstein IJ; Hasty P; Shim EY; Surtees JA; Lee SE
    Nat Commun; 2018 May; 9(1):2025. PubMed ID: 29795289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair.
    Gaillard PHL; Wood RD
    Nucleic Acids Res; 2001 Feb; 29(4):872-9. PubMed ID: 11160918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
    Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
    Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.